文献速递湿疹皮炎与荨麻疹

外用ROR反向激动剂抑制小鼠特应性皮炎与急性刺激性皮炎炎症

Topical ROR Inverse Agonists Suppress Inflammation in Mouse Models of Atopic Dermatitis and Acute Irritant Dermatitis.
PubMed 文献 · J Invest Dermatol · 2017-07-31

研究评估合成RORα/γ反向激动剂SR1001在小鼠特应性皮炎和急性刺激性皮炎模型中的抗炎潜力。外用SR1001可减轻MC903诱导的特应性皮炎样皮损的表皮和真皮特征,抑制2型细胞因子及炎症介质产生,阻断TSLP表达并逆转角质形成细胞分化障碍,对TPA诱导的急性皮炎也有效。提示RORα/γ是皮肤炎症的重要治疗靶点,外用抑制性配体可能用于炎症性皮肤病。

要点

  • 外用SR1001可减轻MC903诱导的小鼠特应性皮炎样皮损。
  • SR1001抑制皮损中2型细胞因子和炎症介质产生。
  • SR1001阻断表皮TSLP表达并逆转角质形成细胞分化障碍。

核心结论

  • RORα/γ是皮肤炎症的重要治疗靶点,外用抑制性配体可能用于治疗炎症性皮肤病。

研究设计与样本

  • 在小鼠特应性皮炎和急性刺激性皮炎模型中研究SR1001(合成RORα/γ反向激动剂)的抗炎作用。

主要发现

  • 外用SR1001减轻MC903诱导的特应性皮炎样病的表皮和真皮特征。
  • SR1001抑制皮损中2型细胞因子和其他炎症介质的产生。
  • SR1001阻断MC903诱导的表皮TSLP表达并逆转受损的角质形成细胞分化。
  • SR1001减轻12-O-十四烷酰佛波醇-13-乙酸酯触发的急性皮炎。

临床怎么用

  • 提示外用RORα/γ反向激动剂可能作为炎症性皮肤病的治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The retinoic acid receptor-related orphan receptors RORα and RORγ are critical for the functions of specific subsets of T cells and innate lymphoid cells, which are key drivers of inflammatory disease in barrier tissues. Here, we investigate the anti-inflammatory potential of SR1001, a synthetic RORα/γ inverse agonist, in mouse models of atopic dermatitis and acute irritant dermatitis. Topical treatment with SR1001 reduces epidermal and dermal features of MC903-induced atopic dermatitis-like disease and suppresses the production of type 2 cytokines and other inflammatory mediators in lesional skin. In the epidermis, SR1001 treatment blocks MC903-induced expression of TSLP and reverses impaired keratinocyte differentiation. SR1001 is also effective in alleviating acute dermatitis triggered by 12-O-tetradecanoylphorbol-13-acetate. Overall, our results suggest that RORα/γ are important therapeutic targets for cutaneous inflammation and suggest topical usage of inhibitory ligands as an approach to treating skin diseases of inflammatory etiology.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Dai J, Choo MK, Park JM, et al. Topical ROR Inverse Agonists Suppress Inflammation in Mouse Models of Atopic Dermatitis and Acute Irritant Dermatitis. J Invest Dermatol. 2017. PMID: 28774591. doi:10.1016/j.jid.2017.07.819

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。